| Literature DB >> 11679561 |
F M Müller1, O Kurzai, J Hacker, M Frosch, F Mühlschlegel.
Abstract
Micafungin (FK-463), a member of the new candin family of antifungal agents, was highly active against clinical isolates of Candida albicans and Candida dubliniensis. The in vitro activity of micafungin suggested that it was more potent than fluconazole, flucytosine, amphotericin B or voriconazole against C. albicans, and comparable or moderately less effective against C. dubliniensis isolates when high-resolution medium (HR) was used. Lower MICs of micafungin were recorded when RPMI 2% or AM3 2% media were used, indicating an influence of the growth medium on the MIC.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11679561 DOI： 10.1093/jac/48.5.713
Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790